Sjögren-Larsson syndrome (SLS) is a rare autosomal recessive neuro-cutaneous disease featuring congenital ichthyotic hyperkeratosis, spastic diplegia and mild to moderate mental retardation. It occurs due to deficiency of microsomal fatty aldehyde dehydrogenase (FALDH) which results in the accumulation of fatty aldehydes and fatty alcohols in various tissues. This rare syndrome has mutations in ALDH3A2 located in chromosome 17p11.2. 1 Neurological symptoms and signs appear during the first 2 years of life and consist of delay in reaching motor milestones due to spastic diplegia or much less commonly, of spastic tetraplegia. Here, we report a case presented with ichthyosis, bilateral lower limb spasticity, and mental retardation, diagnosed as Sjögren-Larsson syndrome.
# CASE REPORT
A 12-year-male patient, born out of non-consanguineous marriage, presented to the Dermatology Department of Nobel Medical College, with generalized dryness of skin, inability to stand and walk along with poor speech. His birth history reveals delivery at pre-term (33 weeks of gestation) by normal vaginal delivery with a birth weight of approximately 2500gm. Although there was no appearance of blister and erythema at any time since birth, his parents noticed generalized scaling since 2 months of age. On detailed history, his symptoms accompanied pruritus and progressive pattern of scaling. There was a delay in motor developmental milestones accompanied by conduction aphasia rendering him to withdraw socially. The similar history was not present in his siblings and other family members. 
DISCUSSION
In 1957, a rare syndrome consisting of congenital ichthyosis, spastic diplegia or tetraplegia (spastic pyramidal symptoms), aphasia associated with low-grade dementia was described by Sjögren and Larsson. 2 The worldwide incidence of Sjögren-Larsson syndrome (SLS) is 0.4 per 100,000 and Over 200 cases are reported across the globe. 3 SLS was linked to fatty alcohol: NAD oxidoreductase (FAO) deficiency. FAO is a complex enzyme containing two different protein moieties which catalyze the oxidation process of fatty alcohol to fatty acids via fatty aldehyde. Further studies done in this field discovered Fatty Aldehyde Dehydrogenase (FALDH) activity in cultured fibroblasts from the patients with SLS signifying the importance of the FALDH component of FAO in SLS patients. FALDH, which is a microsomal enzyme, catalyzes the oxidation of medium and long-chain aliphatic aldehydes derived from numerous metabolisms in the body. 4 More than 70 mutations in ALDH3A2 identified in patients suffering from SLS. 5 Due to mutations, there is abnormal lipid accumulation in the membranes of the brain and skin, the combination of which is an important key for diagnosis. The clinical triad of generalized ichthyosis, mental retardation, and spastic paralysis is the main basis of diagnosis which was our case. Other relevant investigations carried out only for confirmation of the disease.
The pathognomic presence of glistening white dots in macula seen in one-third of cases, which may appear after several years of age. 5 So, this finding is not present in all cases. MRI reveals diffuse symmetrical white matter hyperintensities, especially over periventricular frontal, parietal lobes, corpus callosum, and corona radiate, with sparing of subcortical white matter U fibers. 6 Due to insufficient resources, we report the case only on the basis of clinical findings.
Our case highlights the clinical triad of SLS. It is imperative to consider this rare, but important disease as a differential diagnosis when one deals with any case of ichthyosis. Moreover, family history is also quite important, rendering genetic counseling an option for such families. As skin involvement in this syndrome has greater magnitude, such patients likely go for dermatological consultation before neurological counsel, providing dermatologists an initial chance for proper diagnosis and management.
CONCLUSION
In any case presenting with ichthyosis, spastic diplegia, and mental retardation, it is important to consider SLS as a differential diagnosis though it is a rare disease.
